category,datetime,headline,id,image,related,source,summary,url
company,1768038721,January Dogs Of The Dow: One Ideal 'Safer' Dividend Buy,138055995,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1839458057/image_1839458057.jpg?io=getty-c-w1536,AMGN,SeekingAlpha,January 2026 Dogs of the Dow update: Verizon is the only âdogcatcherâ stock.,https://finnhub.io/api/news?id=1660b2a2ba8c3d9e6bd7a573907b58ceded4a1a0c4d63c9ba3a114cc975bf4d3
company,1768010991,Is It Time To Reassess Amgen (AMGN) After Its 28% One Year Share Price Gain?,138052464,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,AMGN,Yahoo,"If you are wondering whether Amgen's current share price still offers value after a strong run, this article walks through what the numbers are really saying about the stock. Over the last year Amgen has returned 28.4%, with a 3.4% gain over the past 30 days, while the year-to-date return and 7-day move both sit at 0.5% declines, which may have shifted how some investors think about its potential and risk. Recent headlines around Amgen have focused on its position as a large biotech player,...",https://finnhub.io/api/news?id=ba46b45200ece2f690610f0bbc90ef2dac1641197479c7219d344cb5c8fea924
